Cyclodextrin nanoassemblies: A promising tool for drug delivery

Drug Discovery Today

Volumn 20, Issue 9, 2015, Pages 1120-1126

  Bonnet, Véronique ^a   Gervaise, Cédric ^a   Djedaïni Pilard, Florence ^a   Furlan, Aurélien ^a   Sarazin, Catherine ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; NANOPARTICLE; DELAYED RELEASE FORMULATION; DRUG CARRIER;

CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; FORCE; NANODEVICE; PHYSICAL CHEMISTRY; REVIEW; TARGET CELL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG STABILITY; GENE TRANSFER; HUMAN; NANOTECHNOLOGY;

CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GENE TRANSFER TECHNIQUES; HUMANS; NANOPARTICLES; NANOTECHNOLOGY;

EID: 84941023575     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.05.008     Document Type: Review

References (70)

1. K. Riehemann, and et al. Nanomedicine - challenge and perspectives Angew. Chem. Int. Ed. 48 2009 872 897
2. J.L. Arias, and et al. Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics ACS Nano 5 2011 1513 1521
3. D. Paolino, and et al. Supramolecular devices to improve the treatment of brain diseases Drug Discov. Today 16 2011 311 324
4. B. Le Droumaguet, and et al. Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease ACS Nano 6 2012 5866 5879
5. I. Brigger, and et al. Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651
6. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat. Rev. Cancer 5 2005 161 171
7. J.W. Park Liposome-based drug delivery in breast cancer treatment Breast Cancer Res. 4 2002 95 99
8. S. Mura, and et al. Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
9. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
10. S.E.A. Gratton, and et al. The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U. S. A. 105 2008 11613 11618
11. P. Decuzzi, and et al. Intravascular delivery of particulate systems: does geometry really matter? Pharm. Res. 26 2009 235 243
12. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
13. C. Ortiz Mellet, and et al. Cyclodextrins for pharmaceutical and biomedical applications H.J. Schneider, Supramolecular Systems in Biomedical Fields 2013 RSC Publishing 94 139
14. F. Sallas, and R. Darcy Amphiphilic cyclodextrins - advances in synthesis and supramolecular chemistry Eur. J. Org. Chem. 2008 2008 957 969
15. C. Ortiz Mellet, and et al. Cyclodextrin-based gene delivery systems Chem. Soc. Rev. 40 2011 1586 1608
16. A. Mendez-Ardoy, and et al. Polycationic amphiphilic cyclodextrin-based nanoparticles for therapeutic gene delivery Nanomedicine (Lond.) 6 2011 1697 1707
17. S.A. Cryan, and et al. Cationic cyclodextrin amphiphiles as gene delivery vectors J. Drug Del. Sci. Techol. 14 2004 57 62
18. W. Abdelwahed, and et al. Sulfated and non-sulfated amphiphilic-beta-cyclodextrins: impact of their structural properties on the physicochemical properties of nanoparticles Int. J. Pharm. 351 2008 289 295
19. S. Moutard, and et al. Novel glycolipids based on cyclodextrins J. Inclusion Phenom. Macrocyclic Chem. 44 2002 317 322
20. A. Gèze, and et al. Colloidal systems made of biotransesterified alpha, beta and gamma cyclodextrins grafted with C10 alkyl chains Mater. Sci. Eng. C 29 2009 458 462
21. P. Falvey, and et al. Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules Chem. Eur. J. 11 2005 1171 1180
22. E. Bilensoy, and et al. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery Int. J. Pharm. 347 2008 163 170
23. R. Cavalli, and et al. Nanoparticles derived from amphiphilic γ-cyclodextrins J. Inclusion Phenom. Macrocyclic Chem. 57 2007 657 661
24. E. Memişoʇlu, and et al. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes Pharm. Res. 20 2003 117 125
25. E. Memisoglu-Bilensoy, and A.A. Hincal Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving Int. J. Pharm. 311 2006 203 208
26. J.B.G. Yameogo, and et al. Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery Curr. Top. Med. Chem. 14 2014 526 541
27. L. Choisnard, and et al. Efficient size control of amphiphilic cyclodextrin nanoparticles through a statistical mixture design methodology J. Pharm. Pharm. Sci. 8 2005 593 600
28. L. Choisnard, and et al. Miscellaneous nanoaggregates made of β-CD esters synthesised by an enzymatic pathway Int. J. Pharm. 344 2007 26 32
29. B.J. Ravoo, and R. Darcy Cyclodextrin bilayer vesicles Angew. Chem. Int. Ed. 39 2000 4324 4326
30. A. Angelova, and et al. Physico-chemical investigation of asymmetrical peptidolipidyl-cyclodextrins J. Colloid Interface Sci. 322 2008 304 314
31. C. Gervaise, and et al. Synthesis of glycerolipidyl derivatives of permethylated [beta]-cyclodextrin as potential nanovectors New J. Chem. 36 2012 2417 2424
32. C. Ringard-Lefebvre, and et al. Effect of spread amphiphilic β-cyclodextrins on interfacial properties of the oil/water system Colloids Surf. B 25 2002 109 117
33. F. Quaglia, and et al. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs Biomaterials 30 2009 374 382
34. R. Stancanelli, and et al. Amphiphilic cyclodextrins as nanocarriers of genistein: a spectroscopic investigation pointing out the structural properties of the host/drug complex system J. Pharm. Sci. 99 2010 3141 3149
35. D. Nolan, and et al. Preparation of vesicles and nanoparticles of amphiphilic cyclodextrins containing labile disulfide bonds Langmuir 19 2003 4469 4472
36. F. Veronese, and A. Mero The impact of PEGylation on biological therapies BioDrugs 22 2008 315 329
37. B.B. Ghera, and et al. Novel nanoparticles made from amphiphilic perfluoroalkyl α-cyclodextrin derivatives: preparation, characterization and application to the transport of acyclovir Int. J. Pharm. 375 2009 155 162
38. S. Péroche, and et al. Synthesis and characterisation of novel nanospheres made from amphiphilic perfluoroalkylthio-(beta)-cyclodextrins Eur. J. Pharm. Biopharm. 60 2005 123 131
39. M.N.V.R. Kumar Handbook of Particulate Drug Delivery 2007 American Scientific Publishers
40. C. Gervaise, and et al. Synthesis of lipophosphoramidyl-cyclodextrins and their supramolecular properties Biochimie 94 2012 66 74
41. J. Voskuhl, and et al. Sugar-decorated sugar vesicles: lectin-carbohydrate recognition at the surface of cyclodextrin vesicles Chem. Eur. J. 16 2010 2790 2796
42. S.K.M. Nalluri, and B.J. Ravoo Light-responsive molecular recognition and adhesion of vesicles Angew. Chem. Int. Ed. 49 2010 5371 5374
43. J.C. Mathai, and V. Sitaramam Preparation of large uni-lamellar liposomes by the ether injection method and evaluation of the physical integrity by osmometry Biochem. Educ. 15 1987 147 149
44. E. Memisoglu, and et al. Direct formation of nanospheres from amphiphilic β-cyclodextrin inclusion complexes Pharm. Res. 20 2003 117 125
45. E. Memişoʇlu, and et al. Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic b-cyclodextrins Int. J. Pharm. 251 2003 143 153
46. C.W. Lim, and et al. Dynamic multivalent recognition of cyclodextrin vesicles Chem. Commun. 2005 2005 5627 5629
47. A. Mazzaglia, and et al. Probing specific protein recognition by size-controlled glycosylated cyclodextrin nanoassemblies New J. Chem. 30 2006 1662 1668
48. L. Gallego-Yerga, and et al. Glycoligand-targeted core-shell nanospheres with tunable drug release profiles from calixarene-cyclodextrin heterodimers Chem. Commun. 50 2014 7440 7443
49. S. McNicholas, and et al. Amphiphilic N-glycosyl-thiocarbamoyl cyclodextrins: synthesis, self-assembly, and fluorimetry of recognition by Lens culinaris lectin Biomacromolecules 8 2007 1851 1857
50. A. Mazzaglia, and et al. Multivalent binding of galactosylated cyclodextrin vesicles to lectin Org. Biomol. Chem. 2 2004 957 960
51. A. Gèze, and et al. Biodistribution of intravenously administered amphiphilic β-cyclodextrin nanospheres Int. J. Pharm. 344 2007 135 142
52. C. Conte, and et al. Nanoassembly of an amphiphilic cyclodextrin and Zn(II)-phthalocyanine with the potential for photodynamic therapy of cancer RSC Adv. 4 2014 43903 43911
53. A. Mazzaglia, and et al. Supramolecular assemblies based on complexes of nonionic amphiphilic cyclodextrins and a meso-tetra(4-sulfonatophenyl)porphine tributyltin(IV) derivative: potential nanotherapeutics against melanoma Biomacromolecules 14 2013 3820 3829
54. J.B. Harper, and et al. Cyclodextrins to increase the utility of enzymes in organic synthesis Curr. Org. Chem. 4 2000 429 454
55. W. Saenger Cyclodextrin inclusion compounds in research and industry Angew. Chem. Int. Ed. 19 1980 344 362
56. G. Wenz Cyclodextrins as building blocks for supramolecular structures and functional units Angew. Chem. Int. Ed. 33 1994 803 822
57. G. Crini Review: a history of cyclodextrins Chem. Rev. 114 2014 10940 10975
58. J. Szejtli Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1998 1743 1754
59. H. Dodziuk Cyclodextrins and their Complexes 2006 Wiley-VCH 489 pp.
60. E. Bilensoy Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine: Current and Future Industrial Applications 2011 John Wiley & Sons 440 pp.
61. W. Meier Polymer nanocapsules Chem. Soc. Rev. 29 2000 295 303
62. T. Ishihara, and et al. Evasion of the accelerated blood clearance phenomenon by coating of nanoparticles with various hydrophilic polymers Biomacromolecules 11 2010 2700 2706
63. T. Ishida, and H. Kiwada Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes Int. J. Pharm. 354 2008 56 62
64. G.L. Plosker Pegylated liposomal doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myeloma Drugs 68 2008 2535 2551
65. M. Lahiani-Skiba, and et al. Optimization of entrapment of metronidazole in amphiphilic b-cyclodextrin nanospheres J. Pharm. Biomed. Anal. 41 2006 1017 1021
66. Y. Cirpanli, and et al. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery Eur. J. Pharm. Biopharm. 73 2009 82 89
67. E. Memisoglu-Bilensoy, and et al. Tamoxifen citrate loaded amphiphilic b-cyclodextrin nanoparticles: in vitro characterization and cytotoxicity J. Control. Release 104 2005 489 496
68. O. Arnaud, and et al. The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan Eur. J. Cancer 47 2011 640 648
69. E. Memisoglu-Bilensoy, and et al. Effect of drug physicochemical properties on in vitro characteristics of amphiphilic cyclodextrin nanospheres and nanocapsules J. Microencapsul. 23 2006 59 68
70. A. Noomen, and et al. Emulsions of β-cyclodextrins grafted to silicone for the transport of antifungal drugs Mater. Sci. Eng. C 28 2008 705 715